Guidance on Indicating Clinical Trial Vaccines

Issued on December 13, 2021 by AIRA

Guidance on Indicating Clinical Trial Vaccines
Vaccination events that occur as part of clinical trial can be reported to IIS under pre-defined circumstances. This guidance document provides an HL7 method to indicate the vaccination event was part of a clinical trial. It also provides additional considerations related to clinical trial data and an example HL7 message.